Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-28
1996-04-16
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514473, 514474, 549 64, 549 65, 549318, A61K 3138, A61K 3134, C07D33316, C07D30726
Patent
active
055083021
ABSTRACT:
There are disclosed compounds of the formula: ##STR1## wherein R.sup.1 is ##STR2## X is O, or S; Y is O or NOR.sup.2 ;
REFERENCES:
patent: 2916417 (1959-12-01), Horrom
patent: 4285942 (1981-08-01), Budai et al.
patent: 4473597 (1984-09-01), Muryobayashi et al.
patent: 4576962 (1986-03-01), Mattews
patent: 4787749 (1988-12-01), Jacobs et al.
patent: 4816487 (1989-03-01), Scheme et al.
patent: 4874782 (1989-10-01), Bonjouklian et al.
patent: 5013850 (1991-05-01), Lee
patent: 5059611 (1991-10-01), Lee
patent: 5242945 (1993-09-01), Caufield et al.
patent: 5346921 (1994-09-01), Ueno
patent: 5366993 (1994-11-01), Schiehser et al.
Derwent Publication 87-067659/10 corresponding to J62019582 (1987).
Nomura et al., Chem Pharm Bulletin, 34:5188 (1986).
Kataoka et al., Chemical Abstracts, 84:175144m (1976).
Orno et al., Chemical Abstracts, 81:151976w (1974).
American Home Products Corporation
Lambkin Deborah
Milowsky Arnold S.
Raymond Richard L.
LandOfFree
Phospholipase A2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipase A2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase A2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325464